Trump Administration Cuts Endanger Global Health Research Funding

Recent federal funding cuts under the Trump administration are having significant repercussions for health research in the United States and globally. Key agencies such as the CDC, NIH, NSF, and FDA have seen budget reductions, staff layoffs, and program closures, threatening ongoing research projects and collaborations, including those vital for cancer therapies, infectious disease tracking, and university-led scientific discoveries. International partners, like Brazil's Micronutrient Laboratory, are losing access to crucial quality control networks, impeding global standards in public health research. Universities such as the University of Wisconsin face the loss of hundreds of millions in federal research support, jeopardizing life-saving innovation and training for future scientists. Local public health efforts, such as disease surveillance and outbreak response on Martha’s Vineyard, are also at risk, with job losses and data infrastructure cuts already underway. Experts warn these measures undermine progress against chronic and infectious diseases, hinder emerging treatments, and diminish the U.S.'s leadership in biomedical science.